Randomized aldactone evaluation study (RALES) showed that adding aldosterone antagonist in the treatment of heart failure may decrease 30% mortality of all causes.

随内酯评估研究表明在心力衰竭治中加用醛甾酮拮抗药可使总死亡30%。